SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-000480 to Healthcare Triangle, Inc. (HCTI)

Healthcare Triangle, Inc.
Date: Jan. 16, 2024 · CIK: 0001839285 · Accession: 0000000000-24-000480

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-276382

Date
January 16, 2024
Author
Office of Technology
Form
UPLOAD
Company
Healthcare Triangle, Inc.

Letter

United States securities and exchange commission logo January 16, 2024 Thyagarajan Ramachandran Chief Financial Officer Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Re:Healthcare Triangle, Inc. Registration Statement on Form S-3 Filed January 5, 2023 File No. 333-276382 Dear Thyagarajan Ramachandran: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Charli Gibbs-Tabler at 202-551-6388 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc: Ross Carmel

Show Raw Text
United States securities and exchange commission logo
January 16, 2024
Thyagarajan Ramachandran
Chief Financial Officer
Healthcare Triangle, Inc.
7901 Stoneridge Drive, Suite 220
Pleasanton, CA 94588
Re:Healthcare Triangle, Inc.
Registration Statement on Form S-3
Filed January 5, 2023
File No. 333-276382
Dear Thyagarajan Ramachandran:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Charli Gibbs-Tabler at 202-551-6388 with any questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc:       Ross Carmel